Clinical Trials
15 trialsNCT05962606 2026-03-18
Safety and Efficacy of AON-D21 in Severe Community-Acquired Pneumonia.
Aptarion Biotech AG
Phase 2 Completed
NCT04298606 2026-03-17
A Vaccine (CIMAvax-EGF) for the Prevention of Lung Cancer Development or Recurrence
Roswell Park Cancer Institute
Phase EARLY_PHASE1 Completed
NCT04127149 2025-12-19
EPEMedG
Hospices Civils de Lyon
Phase NA Completed
NCT06457269 2024-11-27
EPLLMMRDC
North Sichuan Medical College
Phase NA Completed
NCT04358406 2023-11-28
Rhu-pGSN for Severe Covid-19 Pneumonia
BioAegis Therapeutics Inc.
Phase 2 Completed
NCT04996693 2023-11-22
On Dose Efficiency of Modern CT-scanners in Chest Scans
University Hospital Augsburg
Phase NA Completed
NCT03469271 2023-09-26
Maintain Respiratory Muscle Function and Reduce Pneumonia Risk in Cancer Patients
Mayo Clinic
Phase 4 Completed
NCT01370278 2023-08-25
Clearance Of Mucus In Stents (COMIS)
M.D. Anderson Cancer Center
Phase NA Completed
NCT04453384 2022-03-25
POLYCOR
Nantes University Hospital
Phase 2 Completed
NCT00421174 2021-11-01
BMTCTN0403
National Heart, Lung, and Blood Institute (NHLBI)
Phase 3 Completed
NCT01502072 2021-02-15
Respiratory Syncytial Virus - RSV Protocol
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01386840 2015-05-18
ISPOT
Lata Medical Research Foundation, Nagpur
Phase NA Completed
NCT00029328 2015-03-25
Etanercept for Non-Infectious Lung Injury Following Bone Marrow Transplantation
FDA Office of Orphan Products Development
Phase 1/2 Completed
NCT00081315 2007-08-21
Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer
MedImmune LLC
Phase 2 Completed
NCT00325611 2006-05-15
Multidisciplinary Inpatient Palliative Care Intervention
Kaiser Permanente
Phase NA Completed